LON:AZNAstraZeneca Share Price, Forecast & News

AstraZeneca's stock was trading at GBX 6,955 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization. Since then, AZN shares have increased by 21.9% and is now trading at GBX 8,480. View which stocks have been most impacted by Coronavirus.

20 Wall Street analysts have issued "buy," "hold," and "sell" ratings for AstraZeneca in the last year. There are currently 6 sell ratings, 2 hold ratings and 12 buy ratings for the stock, resulting in a consensus recommendation of "Hold." View analyst ratings for AstraZeneca.

AstraZeneca is scheduled to release its next quarterly earnings announcement on Thursday, July 30th 2020. View our earnings forecast for AstraZeneca.

AstraZeneca declared a dividend on Friday, February 14th. Investors of record on Thursday, February 27th will be given a dividend of GBX 146.40 per share on Monday, March 30th. This represents a dividend yield of 1.92%. The ex-dividend date is Thursday, February 27th. This is a positive change from AstraZeneca's previous dividend of GBX 71.90. The official announcement can be seen at this link. View AstraZeneca's dividend history.

20 equities research analysts have issued 12 month price objectives for AstraZeneca's stock. Their forecasts range from GBX 6,000 to £100. On average, they anticipate AstraZeneca's stock price to reach GBX 8,308.89 in the next year. This suggests that the stock has a possible downside of 2.0%. View analysts' price targets for AstraZeneca.

Press coverage about AZN stock has trended somewhat positive this week, InfoTrie Sentiment reports. The research firm scores the sentiment of news coverage by analyzing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. AstraZeneca earned a coverage optimism score of 1.2 on InfoTrie's scale. They also gave media headlines about the biopharmaceutical company a news buzz of 0.0 out of 10, indicating that recent news coverage is extremely unlikely to have an impact on the company's share price in the next several days. View the latest news about AstraZeneca.

Some companies that are related to AstraZeneca include GlaxoSmithKline (GSK), Bayer (BAYN), Dechra Pharmaceuticals (DPH), Hutchison China MediTech (HCM), Opthea (OPT), Mayne Pharma Group (MYX), Vectura Group (VEC), Medical Developments International (MVP), Eco Animal Health Group (EAH), BEXIMCO PHARMAC/S GDR REGS (BXP), Allergy Therapeutics (AGY), NanoViricides (NNVC), Trilogy International Partners (TRL), Recce Pharmaceuticals (RCE) and Futura Medical (FUM). View all competitors.

Based on aggregate information from My MarketBeat watchlists, some companies that other AstraZeneca investors own include GlaxoSmithKline (GSK), Vodafone Group (VOD), Hain Celestial Group (HAIN), NVIDIA (NVDA), Gilead Sciences (GILD), Royal Dutch Shell (RDSB), Intel (INTC), National Retail Properties (NNN), BP (BP) and Johnson & Johnson (JNJ).

AstraZeneca trades on the London Stock Exchange (LON) under the ticker symbol "AZN."

Shares of AZN and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.

One share of AZN stock can currently be purchased for approximately GBX 8,480.

AstraZeneca has a market capitalization of £111.28 billion and generates £25.25 billion in revenue each year. AstraZeneca employs 64,400 workers across the globe.

The official website for AstraZeneca is www.astrazeneca.com.

AstraZeneca's mailing address is 1 Francis Crick Avenue Cambridge Biomedical Campus, CAMBRIDGE, CB2 0AA, United Kingdom. The biopharmaceutical company can be reached via phone at +44-20-73045000.